Zealand Pharma A/S

kr 232.90As of Sun 8 Nov 2026, 12:00 UTC
CPH:ZEALHealthcare
Country Denmark
PE (Fwd) •••
TSR 10Y CAGR 9.64%
Div yield —
ROE 16.31%
Biotechnology
Beta (5Y) 0.47
PE TTM 6.044
TSR TTM (53.86%)
Mkt cap kr 15.86B
ROIC 56.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 272
16.96%
(54.05%)
Hold 6|6|1|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
7.58
8.28
7.97
8.18
47.14%
49.11%
28.43%
19.31%
Revenuekr M
786.8
802.0
837.7
839.9
6.74%
7.80%
12.76%
8.32%
Peers (US$2.365B)
Cap (US$)
PE
8.031B
39.82x
2.720B
12.41x
740.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.872
0.363
0.343
EBIT/Intx
6.539
0.322
0.345
Own earn%
17.61
16.25
6.09
Sh yield%
25.08
38.66
37.67
Owners
Insiders/Inst%
6.87
78.54
Short interest%
4.34
SBC / revenue%
1.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
18–21
$1 testx
0.0
Incr. ROIC%
3